Christopher M. Crane's most recent trade in Exelon Corp. was a trade of 215,793 Earned Performance RSU done . Disclosure was reported to the exchange on Feb. 8, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exelon | Christopher M. Crane | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 215,793 | 215,793 | - | - | Earned Performance RSU | |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 109,928 | 0 | - | - | Performance Shares 2019-2021 | |
| Exelon | Christopher M. Crane | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 109,928 | 109,928 | - | - | Performance Shares 2019-2021 | |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 109,928 | 404,180 (0%) | 0% | - | Common Stock | |
| Exelon | Christopher M. Crane | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 84,243 | 84,243 | - | - | 2022 Restricted Stock Units | |
| Exelon | Christopher M. Crane | Director, President and CEO | Sale or transfer of securities back to the company at price $ 57.33 per share. | 08 Feb 2022 | 61,205 | 294,252 (0%) | 0% | 57.3 | 3,508,883 | Common Stock |
| Exelon | Christopher M. Crane | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.33 per share. | 08 Feb 2022 | 48,723 | 355,457 (0%) | 0% | 57.3 | 2,793,290 | Common Stock |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 84,514 | 329,175 (0%) | 0% | - | Common Stock | |
| Exelon | Christopher M. Crane | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.73 per share. | 06 Jan 2022 | 34,924 | 294,252 (0%) | 0% | 56.7 | 1,981,239 | Common Stock |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 28,810 | 57,619 | - | - | 2021 Restricted Stock Units | |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 28,254 | 0 | - | - | 2019 Restricted Stock Units | |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 27,450 | 27,450 | - | - | 2020 Restricted Stock Units | |
| Exelon | Christopher M. Crane | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2021 | 285,000 | 0 | - | - | NQ Stock Option (right to buy) 04/02/2012 | |
| Exelon | Christopher M. Crane | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.21 per share. | 19 Nov 2021 | 285,000 | 774,323 (0%) | 0% | 39.2 | 11,174,850 | Common Stock |
| Exelon | Christopher M. Crane | President & CEO | Sale of securities on an exchange or to another person at price $ 53.49 per share. | 19 Nov 2021 | 285,000 | 489,323 (0%) | 0% | 53.5 | 15,244,650 | Common Stock |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 198,406 | 636,403 (0%) | 0% | - | Common Stock | |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 112,368 | 0 | - | - | Performance Shares 2018-2020 (stock units) | |
| Exelon | Christopher M. Crane | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 112,368 | 112,368 | - | - | Performance Shares 2018-2020 (stock units) | |
| Exelon | Christopher M. Crane | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.35 per share. | 25 Jan 2021 | 84,604 | 551,799 (0%) | 0% | 43.3 | 3,667,583 | Common Stock |
| Exelon | Christopher M. Crane | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 83,737 | 83,737 | - | - | 2021 Restricted Stock Units | |
| Exelon | Christopher M. Crane | Director, President and CEO | Sale or transfer of securities back to the company at price $ 43.35 per share. | 25 Jan 2021 | 62,476 | 489,323 (0%) | 0% | 43.4 | 2,708,335 | Common Stock |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 32,075 | 0 | - | - | 2018 Restricted Stock Units | |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 27,369 | 27,374 | - | - | 2019 Restricted Stock Units | |
| Exelon | Christopher M. Crane | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 26,594 | 53,190 | - | - | 2020 Restricted Stock Units |